Inhibition of αvβ5 Integrin Attenuates Vascular Permeability and Protects against Renal Ischemia-Reperfusion Injury

Area of Science:

• Nephrology
• Integrin Biology
• Vascular Biology

Background:

• Ischemia-reperfusion injury (IRI) is a primary cause of acute kidney injury (AKI), often leading to chronic kidney disease (CKD).
• Current therapies for IRI-induced AKI are limited, highlighting the need for novel therapeutic strategies.
• The αvβ5 integrin has been implicated in acute inflammatory conditions, suggesting a potential role in kidney injury.

Purpose of the Study:

• To investigate the role of the αvβ5 integrin in the pathogenesis of renal IRI.
• To evaluate the therapeutic potential of inhibiting αvβ5 integrin in a rat model of kidney IRI.

Main Methods:

• Utilized a function-blocking anti-αvβ5 antibody in a rat model of renal IRI.
• Assessed kidney function via serum creatinine levels and histopathological evaluation.
• Analyzed gene expression profiles and performed intravital imaging to study molecular and vascular changes.
• Investigated αvβ5 function in kidney pericytes using a 3D microfluidics system and in vitro assays.

Main Results:

• Anti-αvβ5 antibody treatment significantly reduced serum creatinine, diminished renal damage, and decreased injury biomarkers.
• Therapeutic administration of the antibody up to 8 hours post-IRI provided protective effects.
• αvβ5 inhibition reduced vascular leak in post-ischemic kidneys and modulated gene expression related to injury pathways.
• αvβ5 plays a pericyte-dependent role in regulating vascular leak, influencing pericyte adhesion and migration.

Conclusions:

• αvβ5 integrin plays a critical role in modulating injury-induced renal vascular leak following IRI, likely via pericyte interactions.
• Inhibition of αvβ5 integrin represents a promising therapeutic strategy for mitigating AKI.
• Further research should explore potential vasomotor effects of αvβ5 inhibition on renal blood flow.